These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
945 related articles for article (PubMed ID: 33410879)
21. Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study. Sichone J; Sinkala M; Munsaka S; Kikonko M; Simuunza M PLoS One; 2021; 16(4):e0249479. PubMed ID: 33822785 [TBL] [Abstract][Full Text] [Related]
22. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493 [TBL] [Abstract][Full Text] [Related]
24. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study. Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
26. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Koo JR; Cook AR; Park M; Sun Y; Sun H; Lim JT; Tam C; Dickens BL Lancet Infect Dis; 2020 Jun; 20(6):678-688. PubMed ID: 32213332 [TBL] [Abstract][Full Text] [Related]
27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
28. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567 [TBL] [Abstract][Full Text] [Related]
29. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review. Oran DP; Topol EJ Ann Intern Med; 2021 May; 174(5):655-662. PubMed ID: 33481642 [TBL] [Abstract][Full Text] [Related]
30. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063 [TBL] [Abstract][Full Text] [Related]
31. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. Paltiel AD; Zheng A; Walensky RP JAMA Netw Open; 2020 Jul; 3(7):e2016818. PubMed ID: 32735339 [TBL] [Abstract][Full Text] [Related]
32. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Grassly NC; Pons-Salort M; Parker EPK; White PJ; Ferguson NM; Lancet Infect Dis; 2020 Dec; 20(12):1381-1389. PubMed ID: 32822577 [TBL] [Abstract][Full Text] [Related]
33. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea. Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296 [TBL] [Abstract][Full Text] [Related]
34. Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2 in a University Student Population, August-November 2020. Krieg SJ; Schnur JJ; Miranda ML; Pfrender ME; Chawla NV Public Health Rep; 2022; 137(5):1023-1030. PubMed ID: 35848117 [TBL] [Abstract][Full Text] [Related]
35. Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination. Moghadas SM; Fitzpatrick MC; Shoukat A; Zhang K; Galvani AP JAMA Netw Open; 2021 Apr; 4(4):e217097. PubMed ID: 33890990 [TBL] [Abstract][Full Text] [Related]
36. International travel-related control measures to contain the COVID-19 pandemic: a rapid review. Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851 [TBL] [Abstract][Full Text] [Related]
37. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Lauer SA; Grantz KH; Bi Q; Jones FK; Zheng Q; Meredith HR; Azman AS; Reich NG; Lessler J Ann Intern Med; 2020 May; 172(9):577-582. PubMed ID: 32150748 [TBL] [Abstract][Full Text] [Related]
38. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090 [TBL] [Abstract][Full Text] [Related]
39. Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data. Casey-Bryars M; Griffin J; McAloon C; Byrne A; Madden J; Mc Evoy D; Collins Á; Hunt K; Barber A; Butler F; Lane EA; O'Brien K; Wall P; Walsh K; More SJ BMJ Open; 2021 Jun; 11(6):e041240. PubMed ID: 34183334 [TBL] [Abstract][Full Text] [Related]
40. Travel-related control measures to contain the COVID-19 pandemic: a rapid review. Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]